Literature DB >> 12074617

The effect of steroids on Dupuytren's disease: role of programmed cell death.

R M D Meek1, S McLellan, J Reilly, J F Crossan.   

Abstract

This study compared the rates of proliferation and apoptosis of cells within nodules of Dupuytren's disease and nodules from patients that had been injected preoperatively with steroid (Depo-Medrone). It also compared the effects of steroids in apoptosis in cultured Dupuytren's cells and control fibroblasts from palmar fascia and fascia lata. Steroids reduced the rate of fibroblast proliferation and increased the rate of apoptosis of both fibroblasts and inflammatory cells in Dupuytren's tissue. Steroids also produced apoptosis of cultured Dupuytren's cells but not of palmar fascia and fascia lata cells. Copyright 2002 The British Society for Surgery of the Hand.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074617     DOI: 10.1054/jhsb.2001.0742

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  15 in total

1.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

2.  Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.

Authors:  Liaquat S Verjee; Jennifer S N Verhoekx; James K K Chan; Thomas Krausgruber; Vicky Nicolaidou; David Izadi; Dominique Davidson; Marc Feldmann; Kim S Midwood; Jagdeep Nanchahal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 3.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Effect of Oral Prednisolone after Collagenase Injection for Dupuytren's Contracture: A Randomized, Controlled Trial with a 1-Year Follow-Up.

Authors:  Yoshihiro Abe
Journal:  J Hand Microsurg       Date:  2020-04-13

5.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

6.  Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.

Authors:  Latha Satish; Phillip H Gallo; Mark E Baratz; Sandra Johnson; Sandeep Kathju
Journal:  BMC Musculoskelet Disord       Date:  2011-05-25       Impact factor: 2.362

7.  Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese Patients.

Authors:  Yoshihiro Abe; Susumu Tokunaga
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-06-05

8.  The Rationale for Treating the Nodule in Dupuytren's Disease.

Authors:  Lynn D Ketchum
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-01-08

Review 9.  Erosive arthropathy with osteolysis as a typical feature in polyfibromatosis syndrome: a case report and a review of the literature.

Authors:  Seong-Kyu Kim; Hyung Joon Kim; Young Hwan Lee; Kyung Jin Suh; Sung-Hoon Park; Jung-Yoon Choe
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

10.  Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.

Authors:  Latha Satish; William A LaFramboise; David B O'Gorman; Sandra Johnson; Benjamin Janto; Bing Siang Gan; Mark E Baratz; Fen Z Hu; J Christopher Post; Garth D Ehrlich; Sandeep Kathju
Journal:  BMC Med Genomics       Date:  2008-04-23       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.